Yayınlar & Eserler

Yayın Ağı
Makaleler 54
Tümü (54)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (47)
ESCI (1)
Scopus (47)
TRDizin (6)
Diğer İndeksler (6)

1. Identification of nonsense variants in the ATM gene mimicking SCID phenotype: a brief report

FIRTINA S., Saritas M., Ng Y. Y., Nepesov S., KIYKIM A., Bozkurt S., et al.
Immunologic Research , cilt.73, sa.1, 2025 (SCI-Expanded) identifier identifier identifier

2. Clinical management of three JMML siblings with germline CBL variation

Agaoglu N. B., Yalcın K., Unal B., Onder G., Celen S. S., Zhumatayev S., et al.
Cancer Genetics , cilt.292-293, ss.120-123, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer

Agaoglu N. B., HATIRNAZ NG Ö., Zemheri I. E., Unal B., Gerenli N., Tosun I., et al.
American Journal of Medical Genetics, Part A , cilt.197, sa.2, 2025 (SCI-Expanded) identifier identifier

4. Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients.

Erbilgin Y., Firtina S., Kirat E., Khodzhaev K., Karakas Z., Ünüvar A., et al.
Biochemical genetics , 2025 (SCI-Expanded, Scopus) identifier

5. Expanding the Phenotypic Spectrum of ERLIN1-Related SPG62: Report of Two Siblings With Behavioral Features and Hyperacusis

Ozkose G. S., TOPÇU Y., Ay B., ÖZDEMİR Ö., AKGÜN DOĞAN Ö., HATIRNAZ NG Ö., et al.
Clinical Genetics , 2025 (SCI-Expanded) identifier identifier

6. Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition

ÖNDER G., ÖZDEMİR Ö., Taylan F., CANPOLAT C., Yalcin K., Erbey F., et al.
Frontiers in Genetics , cilt.16, 2025 (SCI-Expanded) identifier identifier identifier

7. Statistical analysis of genomic in-silico pathogenicity predictors for the characterization of VUS in rare and undiagnosed disorders

AYDIN E., Ergun B., AKGÜN DOĞAN Ö., ALANAY Y., HATIRNAZ NG Ö., ÖZDEMİR Ö.
EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1172, 2024 (SCI-Expanded, Scopus) identifier

8. Long-term immunological changes after corrective cardiac surgery

BİLGİÇ ELTAN S., Amirov R., Babayeva R., Altunbas M. Y., Karakurt T., CAN S., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , cilt.100, sa.6, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. Statistical analysis of genomic in-silico pathogenicity predictors for the characterization of VUS in rare and undiagnosed disorders

AYDIN E., Ergun B., AKGÜN DOĞAN Ö., ALANAY Y., HATIRNAZ NG Ö., ÖZDEMİR Ö.
EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1172, 2024 (SCI-Expanded) identifier

10. Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon

Delgado-Vega A. M., Cederroth H., Taylan F., Ekholm K., Ek M., Thonberg H., et al.
NATURE GENETICS , sa.11, ss.2287-2294, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

11. Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Turkiye

ÖZDEMİR Ö., Bychkovsky B. L., Unal B., ÖNDER G., Amanvermez U., AYDIN E., et al.
CANCERS , cilt.16, sa.22, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey.

Guner Yilmaz B., Akgun-Dogan Ö., Ozdemir Ö., Yuksel B., Hatirnaz Ng Ö., Bilguvar K., et al.
Frontiers in pediatrics , cilt.12, ss.1412880, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

13. Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients

Agaoglu N. B., Unal B., Hayes C. P., Walker M., HATIRNAZ NG Ö., Doganay L., et al.
CANCER MEDICINE , cilt.13, sa.3, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

14. Memantine and SKF82958 but not an enriched environment modulate naloxone-precipitated morphine abstinence syndrome without affecting hippocampal tPA mRNA levels in rats

Aslan A., Hatirnaz-Ng Ö., Tasar O., Ozbek U., Yamanturk-Celik P.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.234, 2024 (SCI-Expanded) identifier identifier identifier identifier

15. A new line method; A direct test in spinal muscular atrophy screening for DBS

Kubar A., Temel S. G., Beken S., Onder G., Hatirnaz Ö., Korkmaz A., et al.
Molecular Genetics and Genomic Medicine , cilt.11, sa.12, 2023 (SCI-Expanded, Scopus) identifier identifier

16. Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey

Lazic J., Haas O. A., Özbek U., Ripperger T., Byrjalsen A., Te Kronnie G., et al.
Pediatric Blood and Cancer , cilt.70, sa.5, 2023 (SCI-Expanded) identifier identifier identifier

17. Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.

Firtina S., Erbilgin Y., Hatirnaz Ng Ö., Karaman S., Karakas Z., Celkan T. T., et al.
Scandinavian journal of clinical and laboratory investigation , cilt.83, sa.3, ss.187-193, 2023 (SCI-Expanded) identifier identifier identifier

18. Obstacles and expectations of rare disease patients and their families in Turkiye: ISTisNA project survey results

Hatirnaz Ng Ö., Sahin I., Erbilgin Y., Ozdemir Ö., Yucesan E., Erturk N., et al.
FRONTIERS IN PUBLIC HEALTH , cilt.10, 2023 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

19. Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family

Agaoglu N. B., HATIRNAZ NG Ö., Unal B., AKGÜN DOĞAN Ö., Amanvermez U., Yildiz J., et al.
CANCER GENETICS , cilt.268-269, ss.128-136, 2022 (SCI-Expanded) identifier identifier identifier identifier

20. Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.

Hatırnaz Ng Ö., Eşkazan A. E.
Translational oncology , cilt.19, ss.101394, 2022 (SCI-Expanded) identifier identifier identifier

21. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls

Senturk G., Ng Y. Y., Eltan S. B., Baser D., Ogulur I., Altindirek D., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , cilt.95, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

22. Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina S., Ng Y. Y., HATIRNAZ NG Ö., Kiykim A., Ozek E. Y., Kara M., et al.
IMMUNOLOGIC RESEARCH , cilt.70, sa.1, ss.44-55, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

23. Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., KARAKAŞ Z., Kucukcankurt F., et al.
LEUKEMIA & LYMPHOMA , cilt.63, sa.12, ss.2931-2939, 2022 (SCI-Expanded, Scopus) identifier identifier identifier identifier

24. Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure.

Hatirnaz N., Akyoney S., Sahin I., Soykam H., Bayram A., Ozdemir Ö., et al.
PloS one , cilt.16, sa.12, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

25. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.

ERBİLGİN Y., Ng Ö., Can I., Firtina S., Kucukcankurt F., KARAMAN S., et al.
International journal of laboratory hematology , cilt.43, sa.5, ss.1093-1103, 2021 (SCI-Expanded) identifier identifier identifier

26. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.

Turan R. D., Tastan C., Kancagi D. D., Yurtsever B., Karakus G. S., Ozer S., et al.
Scientific reports , cilt.11, sa.1, ss.15799, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

27. Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates

Sir Karakus G., Tastan C., Dilek Kancagi D., Yurtsever B., Tumentemur G., Demir S., et al.
SCIENTIFIC REPORTS , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

28. Mutational landscape of severe combined immunodeficiency patients from Turkey

Çekiç Ş., Ng Y. Y., Ng Ö., Kıykım A., Özen A. O., Özen A. O., et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS , cilt.47, sa.6, ss.529-538, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

29. The potential protective roles of zinc, selenium and glutathione on hypoxia-induced TRPM2 channel activation in transfected HEK293 cells

Ergun D. D., Dursun S., PASTACI ÖZSOBACI N., HATIRNAZ NG Ö., NAZIROĞLU M., ÖZÇELİK D.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , cilt.40, sa.6, ss.521-530, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

30. Copy-number variations in adult patients with chronic immune thrombocytopenia.

YÜCESAN E., Ng Ö., Yalniz F. F., Yilmaz H., SALİHOĞLU A., Sudutan T., et al.
Expert review of hematology , cilt.13, sa.11, ss.1277-1287, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

31. Hydrogen Sulphide and Nitric Oxide Cooperate in Cardioprotection Against Ischemia/Reperfusion Injury in Isolated Rat Heart.

ÜSTÜNOVA S., TAKIR S., YILMAZER N., Bulut H., ALTINDİREK D., HATIRNAZ NG Ö., et al.
In vivo (Athens, Greece) , cilt.34, sa.5, ss.2507-2516, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

32. Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S. B., Kebudi R., ALTINDİREK D., Kaya A., Erbilgin Y., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , cilt.40, sa.6, ss.883-892, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia

Kucukcankurt F., Erbilgin Y., Firtina S., Hatirnaz Ö., Karakas Z., Celkan T., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.98-103, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

34. Prognostic gene alterations and clonal changes in childhood B-ALL.

ERBİLGİN Y., Firtina S., Mercan S., Ng Ö., KARAMAN S., Tasar O., et al.
Leukemia research , cilt.83, ss.106159, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

35. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

ERBİLGİN Y., Eskazan A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., Firtina S., et al.
Leukemia & lymphoma , cilt.60, sa.1, ss.200-207, 2019 (SCI-Expanded) identifier identifier identifier

36. Kronik Myeloid Lösemide BCR-ABL Füzyon Transkriptinin Eş Zamanlı PCR ile Kantitasyonu İçin Referans Plazmid Oluşturulması

NG Y. Y., Yılmaz Z. H., HATIRNAZ NG Ö., SAYİTOĞLU M.
Deneysel Tıp Araştırma Enstitüsü Dergisi , cilt.7, sa.13, ss.93-100, 2017 (Hakemli Dergi)

37. A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey.

Firtina S., Ng Y. Y., Ng Ö., Nepesov S., Yesilbas O., Kilercik M., et al.
Immunogenetics , cilt.69, sa.10, ss.653-659, 2017 (SCI-Expanded) identifier identifier identifier

38. Hematolojik Maligniteler Moleküler Genetik Etiyoloji ve 2016 Dünya Sağlık Örgütü Sınıflaması

HATIRNAZ NG Ö., ÖZBEK U.
Türkiye Klinikleri Dergisi Tıbbi Genetik Özel Sayısı , cilt.2, sa.2, ss.88-98, 2017 (Hakemli Dergi)

39. Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia

Firtina S., Hatirnaz Ng Ö., Erbilgin Y., Ozbek U., Sayitoglu M.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.1, ss.357-363, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

40. First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Işil Barlan in Turkey

Ng Y. Y., Şişko S., Hatırnaz Ng Ö., Çatal Tatonyan S., Sever Kaya D., Fırtına S., et al.
Turkish Journal of Immunology , cilt.3, sa.2, ss.47, 2015 (Scopus, TRDizin)

41. First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Isil Barlan in Turkey

Ng Y. Y., Sisko S., HATIRNAZ NG Ö., Tatonyan S. C., ŞATANA D., FIRTINA S., et al.
TURKISH JOURNAL OF IMMUNOLOGY , sa.2, ss.47, 2015 (ESCI) identifier

42. 8q24 bölgesi çocukluk çağı lenfoblastik lösemiler için potansiyel risk oluşturur mu

HATIRNAZ NG Ö., Can İ., SİNEM F., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
Deneysel Tıp Dergisi , cilt.5, sa.9, 2015 (Hakemli Dergi)

43. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia

HATIRNAZ NG Ö., Firtina S., Can I., KARAKAŞ Z., Agaoglu L., DOĞRU Ö., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.127-135, 2015 (SCI-Expanded) identifier identifier identifier identifier

44. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., ERBİLGİN Y., Firtina S., Celkan T., KARAKAŞ Z., Aydogan G., et al.
BLOOD CANCER JOURNAL , cilt.4, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

45. LOCAL RENIN-ANGIOTENSIN SYSTEM IN NORMAL HEMATOPOIETIC AND MULTIPLE MYELOMA-RELATED PROGENITOR CELLS

Haznedaroglu I., Uz B., Ozcebe O., Buyukasik Y., Goker H., Aksu S., et al.
HAEMATOLOGICA , cilt.98, ss.768, 2013 (SCI-Expanded) identifier

46. Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

Maiorov E. G., Keskin O., Ng Ö., Ozbek U., Gursoy A.
BIOMED RESEARCH INTERNATIONAL , 2013 (SCI-Expanded) identifier identifier identifier

47. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., Yildiz I., Celkan T., Anak S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.4, ss.325-333, 2012 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

48. AKUT LÖSEMİ HÜCRE SERİLERİNDE BETA KATENİN siRNA UYGULAMALARI

HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.
DENEYSEL TIP DERGİSİ , cilt.2, sa.3, ss.16-22, 2012 (Hakemli Dergi)

49. Genetic alterations in members of the Wnt pathway in acute leukemia

Erbilgin Y., Ng Ö., Mavi N., Ozbek U., Sayitoglu M.
Leukemia and Lymphoma , cilt.53, sa.3, ss.508-510, 2012 (SCI-Expanded) identifier identifier identifier

50. BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.
DENEYSEL TIP DERGİSİ , cilt.1, sa.2, ss.24-27, 2011 (Hakemli Dergi)

51. Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Koroglu G., Ozbeik U., Cefle K., et al.
Turkish Journal of Gastroenterology , cilt.18, sa.1, ss.53-57, 2007 (SCI-Expanded) identifier identifier identifier

52. HFE gene mutation, chronic liver disease, and iron overload in Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Oezbek U., Demir K., Kaymakoglu S., et al.
Digestive Diseases and Sciences , cilt.52, sa.11, ss.3298-3302, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

53. The SOCS-1 gene methylation in chronic myeloid leukemia patients

Hatirnaz M., Ure U., Ar C., Akyerli C., Soysal T., Ferhanoglu B., et al.
American Journal of Hematology , cilt.82, sa.8, ss.729-730, 2007 (SCI-Expanded) identifier identifier identifier

54. Sayımsal Gerçek Zamanlı Polimer Zincir Reaksiyonu ve Hematolojik Gen Anlatım Analizleri

SAVLI H., HATIRNAZ Ö.
TÜRKİYE KLİNİKLERİ TIP BİLİMLERİ DERGİSİ , cilt.24, sa.6, ss.653-660, 2004 (Hakemli Dergi)